OPOKA INVESTMENT FUND Co's Schedule 13G Filing for BioAtla, Inc.

OPOKA INVESTMENT FUND Co, an investment fund company based in Poland, has filed a Schedule 13G with the SEC, disclosing its ownership of 2,810,331 shares of BioAtla, Inc.'s common stock, representing 4.8% of the total outstanding shares. The filing indicates that the shares are held for investment purposes and not with the intent to influence control of the company. The filing is made under Rule 13d-1(c) and includes certifications that the shares were not acquired for the purpose of changing or influencing the control of the issuer. The event date requiring this filing is July 9, 2025, and the signature date is October 15, 2025.